News Daily News New Dietary Guidelines for Americans Get Mixed Review From Cardiology Community Todd Neale January 12, 2026
News Daily News JACC Debuts Data Digest on CV Health in the United States Caitlin E. Cox January 12, 2026
News Conference News AHA 2025 Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia Michael O'Riordan November 14, 2025
News Conference News AHA 2025 Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol: CORALreef Lipids Michael O'Riordan November 10, 2025
News Conference News AHA 2025 Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV Michael O'Riordan November 08, 2025
News Daily News ACC: It’s Time for Clinicians to Address Inflammation in CVD Caitlin E. Cox October 03, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025
News Daily News Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care Michael O'Riordan February 27, 2025
News Daily News Aspirin Use for Primary Prevention Declining in US: NHANES Michael O'Riordan January 24, 2025
News Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia Michael O'Riordan May 30, 2024
News Conference News ACC 2024 Triglyceride-Lowering Therapies Provide Favorable Outcomes in Early Testing Michael O'Riordan April 12, 2024
News Conference News ACC 2024 Compared With Usual Care, Incorporating Inclisiran Early Cuts LDL Yael L. Maxwell April 09, 2024
News Conference News Lifestyle Changes Can Curb CVD Risk After Adverse Pregnancy Outcomes Yael L. Maxwell March 26, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Daily News Family History of CVD? Low PUFA Intake May Add to Risk Michael O'Riordan December 12, 2023
News Conference News AHA 2023 Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV Todd Neale November 17, 2023
News Conference News AHA 2023 Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation L.A. McKeown November 17, 2023
News Conference News AHA 2023 Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study Michael O'Riordan November 13, 2023